Pages that link to "Q33923908"
Jump to navigation
Jump to search
The following pages link to 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity (Q33923908):
Displaying 20 items.
- Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA (Q30401455) (← links)
- Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus (Q30443535) (← links)
- Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. (Q30477989) (← links)
- Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. (Q30486217) (← links)
- Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: the effect of prior drug exposure (Q30486220) (← links)
- (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats (Q30486621) (← links)
- Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. (Q30495103) (← links)
- Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine (Q33729739) (← links)
- Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats (Q33923867) (← links)
- Developmental effects of 3,4-methylenedioxymethamphetamine: a review (Q33923930) (← links)
- Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine (Q34530062) (← links)
- Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun (Q34721872) (← links)
- Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. (Q34976260) (← links)
- A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) (Q35851128) (← links)
- Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. (Q35944846) (← links)
- Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment (Q37339967) (← links)
- Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. (Q37372727) (← links)
- Drugs, biogenic amine targets and the developing brain (Q37446637) (← links)
- Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression (Q43525141) (← links)
- The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study (Q48383365) (← links)